Immediate Impact
3 from Science/Nature 66 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology
2024 Standout
Works of Quincy Chu being referenced
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
2020
A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Quincy Chu | 129 | 186 | 277 | 18 | 464 | |
| Maral Pourghiasian | 55 | 180 | 238 | 16 | 565 | |
| Kristiina Nordfors | 38 | 53 | 396 | 27 | 500 | |
| Olga Sedlakova | 30 | 116 | 432 | 17 | 564 | |
| Kaori Fujimoto | 50 | 284 | 166 | 24 | 530 | |
| Georges Laı̈n | 41 | 107 | 241 | 11 | 421 | |
| Henri Wichmann | 90 | 106 | 369 | 20 | 550 | |
| Joseph K. Agyin | 36 | 288 | 303 | 12 | 544 | |
| Adrian Staab | 50 | 61 | 251 | 10 | 421 | |
| Eri Sugiyama | 152 | 240 | 190 | 21 | 497 | |
| Alain Gast | 62 | 114 | 254 | 19 | 550 |
All Works
Login with ORCID to disown or claim papers
Loading papers...